Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage
Open Access
- 1 February 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (3), 764-771
- https://doi.org/10.1158/1078-0432.ccr-05-1544
Abstract
Purpose: Melanoma cells express antigens that can induce T-cell and antibody responses. Obtaining a detailed understanding of antigen expression in primary and metastatic melanoma is essential if these molecules are to be useful targets for immunotherapy of melanoma.This publication has 36 references indexed in Scilit:
- NY‐ESO‐1/LAGE‐1 coexpression with MAGE‐A cancer/testis antigens: A tissue microarray studyInternational Journal of Cancer, 2005
- Immunohistochemical and Molecular Analysis of Human Melanomas for Expression of the Human Cancer-Testis Antigens NY-ESO-1 and LAGE-1Clinical Cancer Research, 2004
- Is MAGE-1 Expression in Metastatic Malignant Melanomas Really Helpful?The American Journal of Surgical Pathology, 2004
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissuesInternational Journal of Cancer, 2001
- Monoclonal antibody 57B stains tumor tissues that express geneMAGE-A4International Journal of Cancer, 2000
- Cancer Tumor antigensCurrent Opinion in Immunology, 1997
- Expression of immunotherapy candidate proteins GP100, Mart-1/Melan-A and tyrosinase in human melanocytic lesions and melanoma cell linesMelanoma Research, 1997
- Analysis of Expression of the Melanoma-Associated Antigens MART-1 and gp lOO in Metastatic Melanoma Cell Lines and in In Situ LesionsJournal of Immunotherapy, 1996
- Expression of MAGE genes in primary and metastatic cutaneous melanomaInternational Journal of Cancer, 1995